---
title: "Yowant Technology: Net loss attributable to the parent company in the first half of the year was 253 million yuan, a year-on-year decrease of 15.60%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254475706.md"
description: "On August 25th, Yowant Technology disclosed its semi-annual report, stating that the company achieved operating revenue of 1.896 billion yuan in the first half of the year, a year-on-year decrease of 36.32%; the net loss attributable to shareholders of the listed company was 253 million yuan, a year-on-year decrease of 15.60%; basic earnings per share were -0.2709 yuan"
datetime: "2025-08-25T14:56:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254475706.md)
  - [en](https://longbridge.com/en/news/254475706.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254475706.md)
---

# Yowant Technology: Net loss attributable to the parent company in the first half of the year was 253 million yuan, a year-on-year decrease of 15.60%

On August 25th, Yowant Technology disclosed its semi-annual report, stating that the company achieved operating revenue of 1.896 billion yuan in the first half of the year, a year-on-year decrease of 36.32%; the net loss attributable to shareholders of the listed company was 253 million yuan, a year-on-year decrease of 15.60%; basic earnings per share were -0.2709 yuan

### Related Stocks

- [002291.CN](https://longbridge.com/en/quote/002291.CN.md)

## Related News & Research

- [PharmEasy's parent has a new playbook: Profit first, growth second](https://longbridge.com/en/news/286890424.md)
- [Oops! Dot-com-era stocks are doing it again.](https://longbridge.com/en/news/286542789.md)
- [India's lifeline ferry across strategic archipelago](https://longbridge.com/en/news/286716580.md)
- [TransThera Sciences to Raise HK$156 Million via Discounted H-Share Placement](https://longbridge.com/en/news/286833781.md)
- [Hisense Home Appliances Deploys RMB1.81 Billion into Chongqing Trust Wealth Products](https://longbridge.com/en/news/286888326.md)